Bowen Hanes & Co’s Compugen CGEN Stock Holding History

Bowen Hanes & Co’s Portfolio CGEN Stock Details CGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-680,000	Closed	-$8.23M	–	149
2020 Q4	$8.23M	Buy	680,000 +30,000	+5%	+$414K	0.27%	67
2020 Q3	$10.6M	Buy	+650,000	New	+$10.7M	0.38%	63

Other funds holding CGEN

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Bowen Hanes & Co's CGEN Position: Q1 2021 in Review

Bowen Hanes & Co sold out of Compugen (CGEN) in Q1 2021, closing a stake of 680,000 shares — an estimated $8.23M sold.

Bowen Hanes & Co first reported a position in CGEN in Q3 2020 and held it in 2 quarters. The position peaked at $10.6M in Q3 2020. 108 funds tracked by Wall St. Rank hold CGEN as of Q1 2021.

Bowen Hanes & Co reported no remaining Compugen position as of Q1 2021 after selling out during the quarter.
Bowen Hanes & Co sold 680,000 Compugen shares in Q1 2021, an estimated $8.23M.
Bowen Hanes & Co first reported a position in Compugen in Q3 2020 and held it in 2 quarters.
Bowen Hanes & Co's Compugen position peaked at $10.6M in Q3 2020.
108 funds tracked by Wall St. Rank held Compugen as of Q1 2021.

Based on Bowen Hanes & Co's 13F filing for Q1 2021, filed 13 May 2021.